Skip to main content
Virbac logo

Virbac — Investor Relations & Filings

Ticker · FR000 ISIN · FR0000031577 LEI · 969500QQ1X5XHG649644 PA Manufacturing
Filings indexed 975 across all filing types
Latest filing 2020-03-16 Annual Report
Country FR France
Listing PA FR000

Virbac is an independent pharmaceutical company exclusively dedicated to animal health. Founded in 1968 by a veterinarian, the company provides veterinarians, farmers, and pet owners with a comprehensive range of products and services. Its portfolio of innovative solutions covers the majority of animal species and diseases, with a focus on both companion and farm animals. Key product areas include vaccines, dermatology, parasite control, dental care, nutrition, and diagnostics. Through its international R&D network, Virbac develops solutions to prevent, diagnose, and treat animal pathologies, contributing to animal welfare and supporting sustainable farming.

Recent filings

Filing Released Lang Actions
2019 Consolidated Financial Statements
Annual Report Classification · 95% confidence The document contains detailed consolidated financial statements, including a statement of financial position and an income statement with comparative data for 2018 and 2019. It includes specific notes references (e.g., A1-A3, A21) and covers comprehensive financial performance metrics. Given the length and the presence of substantive financial data, it is classified as an Annual Report (10-K) as it represents the core yearly financial disclosure. FY 2019
2020-03-16 English
Virbac : Déclaration d'actions et de droits de vote Janvier 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "DECLARATION D'ACTIONS ET DE DROITS DE VOTE" (Declaration of Shares and Voting Rights) and explicitly references the total number of voting rights and shares outstanding as of a specific date (January 31, 2020), citing Article 223-16 of the AMF General Regulation. This content directly relates to the official results or status of voting rights and share capital structure, which aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document is short and contains the declaration itself, not an announcement of a separate report.
2020-02-04 French
Virbac : Declaration of the number of shares and voting rights January 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS' and explicitly references compliance with Article 223-16 of the French Financial Market Authority (AMF) regulations. It provides a table detailing the total number of shares and the corresponding gross and net total voting rights as of a specific date (January 31, 2020). This content directly relates to the official declaration of voting rights and share capital structure, which aligns precisely with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not an AGM presentation, a full annual report, or a management change announcement.
2020-02-04 English
VIRBAC : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 31 DECEMBRE 2019
Regulatory Filings Classification · 99% confidence The document is titled "BILAN SEMESTRIEL DES MOYENS ALLOUES AU CONTRAT DE LIQUIDITE" (Semi-annual balance sheet of means allocated to the liquidity contract) for VIRBAC, dated January 22, 2020, and reports on the status of a liquidity contract (likely a share buyback/stabilization agreement) as of December 31, 2019, comparing it to previous periods (June 30, 2019, and December 31, 2018). This type of report details transactions involving the company's own shares under a specific agreement, which aligns directly with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase programs.
2020-01-22 French
Virbac: chiffre d’affaires annuel 2019 en forte croissance de +6,6% à taux de change constants
Earnings Release Classification · 100% confidence The document is a press release dated January 16, 2020, titled 'Chiffre d'affaires annuel 2019 en forte croissance de +6,6% à taux de change constants' (Annual Revenue 2019 in strong growth of +6.6% at constant exchange rates). It details quarterly and cumulative annual revenue figures for 2019 compared to 2018, including segment and geographic breakdowns. It also provides outlook/perspectives for 2020. This content structure—a summary of financial results for a completed period (annual) released shortly after the period ends, often containing key highlights and outlook—is characteristic of an Earnings Release (ER). While it contains annual figures, it is presented as a press release announcing those results, not the full, audited 10-K report. It is too detailed for just a 'Report Publication Announcement' (RPA) and is clearly the primary financial results announcement. FY 2019
2020-01-16 French
Virbac: 2019 annual revenue shows strong growth of +6.6% at constant exchange rates
Earnings Release Classification · 100% confidence The document is explicitly titled as a 'Press release issued on January 16, 2020' and provides a summary of the '2019 annual revenue' showing strong growth, along with detailed quarterly consolidated revenue figures for Q4 2019 and cumulative annual revenue for 2019 compared to 2018. It also includes an 'Outlook' section for 2020. This structure—a press release announcing key financial highlights for a period (the full year 2019)—is characteristic of an Earnings Release (ER), which provides initial, high-level results, rather than the comprehensive 10-K or the detailed Management Discussion and Analysis (MDA). It is not a full transcript (CT) or a formal regulatory filing like a 10-K. FY 2019
2020-01-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.